Print

Amgen (AMGN) Deploys up to 1,000 Reps on Prolia Approval  
6/3/2010 7:55:08 AM

mmm-online.com -- Amgen has deployed “500 to 1,000” reps in support of Prolia (denosumab), a biologic osteoporosis treatment that received FDA approval on June 1. The drug was approved in the European Union on May 28.
//-->